Inventor · disambiguated record
Jeffrey Gardner
Also filed as: GARDNER JEFFREY · GARDNER JEFFREY R
10 granted patents·10 pending applications·34 citations·filing 2014–2025
87Inventor score
Files withADJUVANCE TECH INC10MEMORIAL SLOAN KETTERING CANCER CENTER4ARGENTUM PHARMACEUTICALS LLC2SLOAN KETTERING INST CANCER RES2MEMORIAL SLOAN-KETTERING INST FOR CANCER RES1
Top patents by PatentIndex Score
20 records- 0192US10906926B2Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2020·Granted Feb 2, 2021·6 cites·21 claims
- 0291US11274116B2Minimal saponin analogues, synthesis and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Mar 15, 2022·3 cites·10 claims
- 0387US9718850B2Triterpene saponins, methods of synthesis and uses thereofMEMORIAL SLOAN-KETTERING INST FOR CANCER RES·Filed 2014·Granted Aug 1, 2017·15 cites·4 claims
- 0486US10626137B2Minimal saponin analogues, synthesis and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Apr 21, 2020·2 cites·5 claims
- 0585US11447515B2Triterpene saponins, methods of synthesis and uses thereofSLOAN KETTERING INST CANCER RES·Filed 2017·Granted Sep 20, 2022·2 cites·1 claims
- 0683US11324821B2Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2018·Granted May 10, 2022·5 cites·13 claims
- 0782US12227535B2Triterpene saponins, methods of synthesis and uses thereofSLOAN KETTERING INST CANCER RES·Filed 2022·Granted Feb 18, 2025·0 cites·4 claims
- 0880US11135197B2Dosage regimen of an S1P receptor modulatorARGENTUM PHARMACEUTICALS LLC·Filed 2021·Granted Oct 5, 2021·1 cites·8 claims
- 0978US12187755B2Minimal saponin analogues, synthesis and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Granted Jan 7, 2025·0 cites·13 claims
- 1078US12037355B2Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2023·Granted Jul 16, 2024·0 cites·20 claims
- 1177US2024327443A1Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2024·Application pending·0 cites
- 1274US2025188109A1Triterpene saponins, methods of synthesis, and uses thereofSLOAN KETTERING INSITUTE FOR CANCER RES·Filed 2025·Application pending·0 cites
- 1368US2025223311A1Minimal saponin analogues, synthesis and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
- 1466US2023357300A1Triterpene saponin synthesis, intermediates and adjuvant combinationsADJUVANCE TECH INC·Filed 2023·Application pending·0 cites
- 1564US2021002316A1Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2020·Application pending·0 cites
- 1660US2022184207A1Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2022·Application pending·0 cites
- 1758US2018327436A1Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2016·Application pending·0 cites
- 1857US2021338635A1Dosage Regimen for the Treatment of Multiple Sclerosis with a S1P Receptor ModulatorARGENTUM PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1945US2021299237A1Triterpene saponin synthesis, intermediates and adjuvant combinationsADJUVANCE TECH INC·Filed 2018·Application pending·0 cites
- 2042US2020164065A1Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey Gardner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →